Monte Rosa Therapeutics
GLUE
GLUE
69 hedge funds and large institutions have $310M invested in Monte Rosa Therapeutics in 2023 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 22 increasing their positions, 20 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1% less capital invested
Capital invested by funds: $314M → $310M (-$3.96M)
4.62% less ownership
Funds ownership: 85.19% → 80.57% (-4.6%)
Holders
69
Holding in Top 10
2
Calls
$594K
Puts
–
Top Buyers
| 1 | +$2.92M | |
| 2 | +$2.04M | |
| 3 | +$1.59M | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$744K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$290K |
Top Sellers
| 1 | -$9.24M | |
| 2 | -$3.89M | |
| 3 | -$2.15M | |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$1.69M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.59M |